Bioorganic and Medicinal Chemistry p. 1167 - 1176 (1996)
Update date:2022-08-04
Topics:
Kiyoi, Takao
Nakai, Yoshiyuki
Kondo, Hirosato
Ishida, Hideharu
Kiso, Makoto
Hasegawa, Akira
A practical synthesis of the sialyl Lewis X (sLe(x)) pentasaccharide, NeuAcα2-3Galβ1-4(Fucα1-3)GlcNAcβ1-3GalβOEt (1), as a potential blocker for E-selectin has been described. The glycosylation of a trisaccharide acceptor, Fucα(1-3)GlcNAcβ(1-3)GalβOEt, with a disaccharide donor, NeuAcα(2-3)GalβSMe, did not yield the desired sLe(x) pentasaccharide 1 at all. However, the glycosylation of a disaccharide acceptor, GlcNAcβ(1-3)GalβOEt, with a disaccharide donor, NeuAcα(2-3)GalβSMe, quantitatively yielded the tetrasaccharide NeuAcα(2-3)Galβ(1-4) GlcNAcβ(1-3)GalβOEt. This tetrasaccharide is readily converted to the title compound in a high yield by fucosylation, followed by deprotection. The inhibitory activities of compound 1 toward the binding of the natural ligand (sLe(x)) with the E-, P-, and L-selectins were stronger than those of the sLe(x) tetrasaccharide.
View MoreSICHUAN ZHONGBANG NEW MATERIAL CO., LTD
website:http://www.zhongbangst.com
Contact:86-830-2585019
Address:sichuan,china
website:http://www.np-chem.com
Contact:0086-25-52346877
Address:199, Jian Ye Road, Nanjing, China
Shanghai Xinda Pharmaceuticals Co., Ltd.
Contact:86-21-33692333-8008
Address:999 Linxian Road, Jinshan Industrial Park, Shanghai, China
Shandong Bolode Bio-Technology Co., LTD
Contact:+86-0531-58966870
Address:136 Jingyi Road,Huaiyin District,Jinan,Shandong,China
Anhui New Star Pharmaceutical Development Co., Ltd
Contact:013956922763
Address:Floor 3, F9A, F Workshop, No.110 Kexue Road, High-Tech Development Zone, Hefei, Anhui ,China
Doi:10.1038/nchem.2672
(2017)Doi:10.1021/jo9612685
(1996)Doi:10.1002/anie.199621411
(1996)Doi:10.1016/j.jorganchem.2003.08.032
(2003)Doi:10.1016/0040-4039(96)01820-5
(1996)Doi:10.1246/cl.1996.987
(1996)